Kit integrating three proteins such as Kindlin-2, Myosin-9 and Annexin II for prognosis evaluation of patient suffering from esophageal squamous cell carcinoma
A technology of esophageal squamous cell carcinoma and a kit is applied in the field of kits for predicting the prognosis of patients, which can solve the problems of unclear prognosis of patients with Kindlin-2 expression.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0013] We collected archival wax blocks of surgical specimens from 110 patients with esophageal squamous cell carcinoma from 2000 to 2006. Further detailed description will be given below in conjunction with the embodiments of the accompanying drawings.
[0014] The steps of immunohistochemical hypersensitivity two-step method are as follows:
[0015] After the specimens were serially sectioned, dewaxed with xylene, and hydrated with graded alcohol, the expression of the target protein was detected by an ultrasensitive two-step method.
[0016] The specific method is as follows:
[0017] (1) The slices were repaired with 0.01M citrate repair solution, 3% H 2 o 2 After inactivating endogenous peroxidase and blocking with goat serum, incubate with Annexin II, Kindlin-2 and Myosin-9 antibodies overnight at 4°C;
[0018] (2) After the sections were incubated with Polymer enhancer and Polymer polymer, the color was developed by DAB;
[0019] (3) The sections were counterstaine...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com